Bloomlife

Bloomlife

FDA-cleared remote maternal-fetal monitoring platform

Overview

Bloomlife provides a remote prenatal care platform for healthcare providers using the FDA-cleared MFM-Pro wearable patch to non-invasively monitor maternal and fetal heart rates outside the clinic. Clinicians prescribe the patch; patients wear it; data is collected and interpreted by clinical teams and fed into EMR systems, while Bloomlife handles logistics and the service is reimbursed through insurers. It differentiates itself by targeting high-risk pregnancies with a clinically focused, prescription-based B2B2C model that integrates with EMRs and third-party devices, rather than selling directly to consumers. Its goal is to make prenatal care safer and more accessible by reducing in-clinic visits and manual monitoring while improving maternal and fetal health management.

About Bloomlife

Simplify's Rating
Why Bloomlife is rated
B-
Rated B on Competitive Edge
Rated B on Growth Potential
Rated C on Differentiation

Industries

Data & Analytics

Enterprise Software

Healthcare

Company Size

11-50

Company Stage

Series A

Total Funding

$26.8M

Headquarters

San Francisco, California

Founded

2014

Get referred to Bloomlife

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • Bloomlife raised $12.2 million in September 2024 for commercial expansion and device development.
  • Valley Perinatal Services partnered in January 2026, validating clinical demand in Arizona.
  • Website updates in August 2026 show active commercialization, support, and reimbursement messaging.

What critics are saying

  • Reimbursement dependence exposes Bloomlife to payer denials and coding changes across 2026.
  • Valley Perinatal and PeriGen partnerships make distribution dependent on provider adoption speed.
  • A failed second device launch after the Series A would cripple growth and investor confidence.

What makes Bloomlife unique

  • FDA-cleared MFM-Pro monitors maternal and fetal heart rates remotely, updated August 2026.
  • Bloomlife Connects integrates connected devices, analytics, and EMR workflows for high-risk prenatal care.
  • PeriGen partnership adds AI-driven clinical decision support, strengthening specialist workflow integration since January 2024.

Help us improve and share your feedback! Did you find this helpful?

Funding

Total Funding

$26.8M

Below

Industry Average

Funded Over

5 Rounds

Series A funding typically happens when a startup has a product and some customers, and now needs funding to scale. This money is usually used to grow the team, expand marketing, and improve the product. Venture capital firms are frequently the main investors here.
Series A Funding Comparison
Below Average

Industry standards

$15M
$8.2M
Discord
$12.2M
Bloomlife
$15M
Canva
$30M
Kalshi

Benefits

Health Insurance

Dental Insurance

Vision Insurance

Unlimited Paid Time Off

Paid Sick Leave

Paid Vacation

401(k) Retirement Plan

Parental Leave

Stock Options

Flexible Work Hours

Remote Work Options

Professional Development Budget

Growth & Insights and Company News

Headcount

6 month growth

2%

1 year growth

2%

2 year growth

0%
Femtech Insider
Jan 15th, 2024
Bloomlife Raises $12.2M for Maternal Care

Bloomlife has raised $12.2 million in a Series A funding round led by Kapor Capital and Noshaq, with participation from RH Capital, 15th Rock Ventures, The Grove Foundation, Stardust Equity, and Lean Square. The funds will support the commercial expansion and development of a new FDA-cleared device. CEO Eric Dy highlighted the need for more efficient, patient-centered maternal care, emphasizing the benefits of digitizing healthcare systems for better patient outcomes.

Recently Posted Jobs

Sign up to get curated job recommendations

Bloomlife is Hiring for 2 Jobs on Simplify!

Find jobs on Simplify and start your career today

Don't see your dream role? Check out thousands of other roles on Simplify. Browse all jobs →